About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 257 record(s)
Req # A-2021-000353
Adverse Drug Reaction (ADR) for ROSUVASTATIN CALCIUM. Report number: E2B_03467451.Organization: Health Canada
October 2021
Req # A-2021-000372
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03820452.Organization: Health Canada
October 2021
Req # A-2021-000374
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03809058.Organization: Health Canada
October 2021
Req # A-2021-000633
Adverse Drug Reactions (ADRs) for METFORMIN HYDROCHLORIDE. Report numbers: E2B_03482740, E2B_02691752.Organization: Health Canada
October 2021
Req # A-2021-000660
Adverse Drug Reaction (ADR) for PREDNISONE. Report number: E2B_03501659.Organization: Health Canada
October 2021
Req # A-2021-000700
Adverse Drug Reactions (ADRs). Report numbers: E2B_03496486, E2B_03092641.Organization: Health Canada
October 2021
Req # A-2021-000739
Adverse Drug Reaction (ADR) for HYDROCHLOROTHIAZIDE. Report number: E2B_03406806.Organization: Health Canada
October 2021
Req # A-2021-000793
Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: E2B_03379657, E2B_03456958, E2B_03508675.Organization: Health Canada
October 2021
Req # A-2021-000879
Adverse Drug Reaction (ADR) for PARACETAMOL. Report number: E2B_03508760.Organization: Health Canada
October 2021
Req # A-2021-001032
Adverse Drug Reaction (ADR) for IRBESARTAN. Report number: E2B_03788609.Organization: Health Canada
October 2021